Back to top

Enliven price target raised to $75 from $60 at Baird

Baird raised the firm’s price target on Enliven (ELVN) to $75 from $60 and keeps an Outperform rating on the shares. The firm updated its model fol...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enliven Therapeutics, Inc. (ELVN)